GlassScriptPhysician profile
Matthew C Davis
NPI 1164764445
$3,408.32
in general payments reported to CMS, 2019-2025
22 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,549 · 2020: $60.16 · 2021: $1,076 · 2022: $218 · 2023: $281 · 2024: $70.23 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monteris Medical Corporation | $1,486.12 | 2019 | |
| Abbott Laboratories | $629.16 | 2021 | |
| Medtronic, INC. | $363.81 | 2021-2025 | Intellis Adaptivestim, Percept PC Brainsense, Synchromedii |
| Boston Scientific Corporation | $349.74 | 2021-2025 | Vercise |
| Cerapedics INC. | $95.83 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $78.69 | 2020-2023 | Matrixneuro, Synthecel |
| Orthofix Medical, INC. | $51.12 | 2022-2023 | 7d Surgical System |
| Medtronic USA, INC. | $47.93 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $40.07 | 2023 | Andexxa |
| Silk Road Medical, INC. | $32.43 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Osteomed LLC | $31.54 | 2019 | |
| Seaspine Orthopedics Corporation | $28.91 | 2022 | |
| Amneal Pharmaceuticals LLC | $27.96 | 2023 | Lioresal (Baclofen) |
| Kls-Martin L.P. | $22.12 | 2022 | |
| Si-Bone, INC. | $18.68 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $17.26 | 2022 | |
| Alexion Pharmaceuticals, INC. | $16.79 | 2022 | |
| Inspire Medical Systems, INC. | $15.56 | 2023 | Inspire |
| Nevro Corp. | $15.54 | 2022 | |
| Irras USA, INC. | $13.36 | 2020 | |
| Arteriocyte Medical Systems, INC. | $13.34 | 2023 | Magellan |
| Cardiva Medical, INC. | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.